Skip to main content

PUREVAX Recombinant FeLV (1 mL)

This page contains information on PUREVAX Recombinant FeLV (1 mL) for veterinary use.
The information provided typically includes the following:
  • PUREVAX Recombinant FeLV (1 mL) Indications
  • Warnings and cautions for PUREVAX Recombinant FeLV (1 mL)
  • Direction and dosage information for PUREVAX Recombinant FeLV (1 mL)

PUREVAX Recombinant FeLV (1 mL)

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health



Feline Leukemia Vaccine

Live Canarypox Vector

PUREVAX Recombinant FeLV (1 mL) Indications

This product has been shown to be effective for the vaccination of healthy cats 8 weeks of age or older against feline leukemia virus. The duration of immunity has not been determined. For more information regarding efficacy and safety data, see


PureVax® Recombinant FeLV contains a non-adjuvanted lyophilized suspension of a recombinant vectored feline leukemia vaccine plus sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to feline leukemia. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.

Directions and dosage: Aseptically rehydrate the lyophilized vaccine with 1 mL of the accompanying sterile water diluent, and agitate. Administer 1 mL (1 dose) subcutaneously.

For primary vaccination, cats should receive two 1 mL dose vaccinations, three weeks apart. For advice on revaccination frequency, consult your veterinarian. Diagnostic testing for FeLV prior to vaccination is recommended.

Precautions: Use entire contents immediately following rehydration. Contains gentamicin as a preservative. This product has not been tested in pregnant cats. In rare instances, administration of vaccines may cause transient pain associated with injection, lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact a physician.

Inactivate unused contents before disposal.

Store at 2-8°C (35-46°F). Do not freeze. Do not mix with other products, except as specified on the label.

For use in animals only.

Sold to veterinarians only.

PUREVAX® is a registered trademark of the Boehringer Ingelheim Animal Health France SCS, used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601 USA

Tel: 1 (888) 637-4251

VLN/PCN 124/1555.R4

Distributed in Canada by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4



25 doses

25 x 1 Dose, Lyophilized

25 x 1 Dose (1 mL), Sterile diluent


CPN: 1028363.0

Telephone:   800-325-9167
Customer Service:   888-637-4251
Technical Service:   888-637-4251
Fax:   816-236-2717
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2023-11-27